CNSDose
Hospital & Health Care - , ,
CNSDose Employees
CNSDose Senior Management
CNSDose Details
A University of Melbourne & Texas Medical Center backed Australian Precision Medicine software company. Aim: Fast-Track finding the right antidepressant with genetics.CNSDose activated AmplisEvo in 2020 - our FDA harmonized cutting edge evidence backed blood-brain-barrier pharmacogenetic powered report. A large fully independent randomized controlled trial to confirm clinical utility in complex depression starts recruiting in 2021. If positive, CNSDose may well be declared the gold standard in the segment globally. Watch this space.CNSDose partners with exclusive lab distributors globally, our cloud platform turns 50 gene variants into a simple medication guidance report. We're interoperable with most genotyping arrays and lab information system platforms. Email our founder direct (a practicing psychiatrist) on aprofsingh@gmail.com to explore commercial opportunities.
CNSDose Technologies
E-commerce Platforms
Woo Commerce
Email Providers
Outlook
Fonts
Google Font API
Tag Management
Google Tag Manager
Other
Mobile Friendly